The Laboratory Animal, Tumor Testing and Intervention Core (LAC) is a shared resource that provides state of- the-art, quality, affordable, and accessible animal maintenance and research services to Cancer Center researchers. The Laboratory Animal Core (LAC) began operations in 1987 and now consists of animal husbandry, housing and care services, as well as animal model tumor testing, experimental treatment and intervention services. The objective of the LAC is to facilitate basic, pre-clinical and translational cancer research and to provide Cancer Center investigators with high quality, centralized standard animal care and specialized services for reproducible and reliable animal experimentation and in vivo tumor growth studies at cost effective prices. The LAC serves Cancer Center members at the 9th Avenue and the Fitzsimons campuses;and at the Denver Veterans Affairs Medical Center, Denver Health and Hospitals, AMC Cancer Research Center and National Jewish Medical and Research Center. The investigators served by the Core represent all eight of the Cancer Center Programs. Planned future developments include the coordination of animal studies with the developing Animal Imaging and Radiation Sciences Cores;the expansion of pathological services with the recruitment of a board certified Veterinary Pathologist;and completion and occupation of the second phase of the move to the new facilities on the Fitzsimons campus.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-25S2
Application #
8710578
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
25
Fiscal Year
2013
Total Cost
$961
Indirect Cost
$339
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kessler, Elizabeth R; Su, Lih-Jen; Gao, Dexiang et al. (2018) Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integr Cancer Ther 17:1103-1108
Fitzwalter, Brent E; Towers, Christina G; Sullivan, Kelly D et al. (2018) Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover. Dev Cell 44:555-565.e3
Duex, Jason E; Swain, Kalin E; Dancik, Garrett M et al. (2018) Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer. Mol Cancer Res 16:69-77
Graybill, Chiharu; Morgan, Michael J; Levin, Myron J et al. (2018) Varicella-zoster virus inhibits autophagosome-lysosome fusion and the degradation stage of mTOR-mediated autophagic flux. Virology 522:220-227
Wheeler, Lindsay J; Watson, Zachary L; Qamar, Lubna et al. (2018) CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis 7:92
Klauck, Peter J; Bagby, Stacey M; Capasso, Anna et al. (2018) Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer. BMC Cancer 18:136
Klein, Brianna J; Ahmad, Salar; Vann, Kendra R et al. (2018) Yaf9 subunit of the NuA4 and SWR1 complexes targets histone H3K27ac through its YEATS domain. Nucleic Acids Res 46:421-430
Yang, Jianquan; Xu, Jingli; Gonzalez, Rene et al. (2018) 68Ga-DOTA-GGNle-CycMSHhex targets the melanocortin-1 receptor for melanoma imaging. Sci Transl Med 10:
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54

Showing the most recent 10 out of 1634 publications